FDA Clearance Tracker · K210254
MeMed BV
Last checked: Nov 19, 2026Latest source record: Sep 1, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Sep 1, 2021
Substantially Equivalent
Time to decision
215 days
Received Jan 29, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K210254
- Device name
- MeMed BV
- Applicant
- MeMed Diagnostics, Ltd.
- Applicant location
- Tirat Carmel, IL
- Received
- Jan 29, 2021
- Decided
- Sep 1, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3215
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QPS (Immunoassay For Host Biomarkers Of Infection).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K210254
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for MeMed Diagnostics, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MeMed BV510(k)
K230944 · Decided Jun 30, 2023 · 87 days after receipt
Device type: Immunoassay For Host Biomarkers Of Infection (QPS) · Laboratory Medicine & Pathology
- MeMed BV510(k)
K222332 · Decided Mar 23, 2023 · 233 days after receipt
Device type: Immunoassay For Host Biomarkers Of Infection (QPS) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.